1. Home
  2. News Releases
  3. Back Issues
  4. June FY2020
  5. Addition of Pharmaceutical and Special Medical Device Manufacturing businesses, to Core Designated Business Sectors Subject to Inward Direct Investment Screening

Addition of Pharmaceutical and Special Medical Device Manufacturing businesses, to Core Designated Business Sectors Subject to Inward Direct Investment Screening

June 15, 2020

On June 15, 2020, the government of Japan publicized the public notices of revision in an official gazette concerning the addition of manufacturing business involving pharmaceuticals for specific infectious diseases manufacturers as well as specially-controlled medical devices manufacturers to the core designated business sectors subject to inward direct investment screening.

1. Outline of the revision

In light of recent expansion of the novel coronavirus disease, the government considers it important to maintain the base of domestic medical manufacturing industries which are significant to public health and to appropriately prevent situations that may cause serious impacts on national security and health. From these viewpoints, the government decided to take necessary measures, and include the addition of:

*Note: The related public notices are:

The Public Notice of the Designated Business Sectors The Public Notice of the Core Designated Business Sectors

2. Future schedule

The provisions in the public notices of the revised core/designated business sectors hereby publicized will be applied to inward direct investment, etc. undertaken on or after July 15, 2020, the date after the grace period of 30 days.

For further detail, please see the Japanese language press release.

Division in Charge

Security Trade Control Policy Division, Trade Control Department, Trade and Economic Cooperation Bureau

Related website